These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 22122079)

  • 21. Epigenetic regulation of HIV-1 transcription.
    Tripathy MK; Abbas W; Herbein G
    Epigenomics; 2011 Aug; 3(4):487-502. PubMed ID: 22126207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetics and cancer treatment.
    Kristensen LS; Nielsen HM; Hansen LL
    Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone modifications and cancer.
    Sawan C; Herceg Z
    Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?
    Kobow K; Blümcke I
    Epilepsia; 2011 Jul; 52 Suppl 4():15-9. PubMed ID: 21732935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin modifier enzymes, the histone code and cancer.
    Santos-Rosa H; Caldas C
    Eur J Cancer; 2005 Nov; 41(16):2381-402. PubMed ID: 16226460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
    Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
    Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of epigenetic inheritance.
    Martin C; Zhang Y
    Curr Opin Cell Biol; 2007 Jun; 19(3):266-72. PubMed ID: 17466502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.
    Epping MT; Bernards R
    Int J Biochem Cell Biol; 2009 Jan; 41(1):16-20. PubMed ID: 18765293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin-modifying agents in anti-cancer therapy.
    Seidel C; Florean C; Schnekenburger M; Dicato M; Diederich M
    Biochimie; 2012 Nov; 94(11):2264-79. PubMed ID: 22627380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards targeted epigenetic therapy of cancer.
    Magic Z; Supic G; Brankovic-Magic M
    J BUON; 2009 Sep; 14 Suppl 1():S79-88. PubMed ID: 19785074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review).
    Emanuele S; Lauricella M; Tesoriere G
    Int J Oncol; 2008 Oct; 33(4):637-46. PubMed ID: 18813776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin modifying agents - the cutting edge of anticancer therapy.
    Kwa FA; Balcerczyk A; Licciardi P; El-Osta A; Karagiannis TC
    Drug Discov Today; 2011 Jul; 16(13-14):543-7. PubMed ID: 21664485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.